Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mydriasert versus phenylephrine plus tropicamide for pre-cataract surgery mydriasis
2013-000292-33Phase 4Terminated
- Sponsor
- Laura Sararols Ramsay
- Start
- Sep 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Mydriasert, phenylephrine and tropicamide in cataract and senile cataract (ARC) (2 arms), sponsored by Laura Sararols Ramsay. Primary endpoint: Mydriasis at capsulorrhexis. Started Sep 2013; status: terminated.
02
Drugs
Mydriasertphenylephrinetropicamide
03
Conditions
cataractsenile cataract (ARC)
Beyond the preview
Go deeper on 2013-000292-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000292-33.